Nutrition, metabolism, and cardiovascular longevity-what is established, what is hypothesis?

Authors: Rossmeissl, A; Timper, K

Source journal: Herz (2026-11-20)

DOI: 10.1007/s00059-026-05400-x

Abstract

BACKGROUND: Cardiovascular aging is the rate-limiting process for human life expectancy and healthspan. Nutrition and metabolism are the most widely available geroprotective targets, yet the underlying evidence is markedly uneven. OBJECTIVE: To define which nutritional and metabolic interventions are established for cardiovascular longevity, or better healthy aging, and which remain hypothetical. METHODS: Narrative review of randomized trials, cohort studies, and mechanistic work on dietary patterns, energy balance, meal timing, food quality, supplements, and biomarkers of biological aging. RESULTS: Whole dietary patterns (Mediterranean, "Dietary Approaches to Stop Hypertension" [DASH], sodium reduction) reduce hard cardiovascular endpoints, and the causal roles of apolipoprotein B (apoB)-containing lipoproteins, blood pressure, and adiposity are firmly established. Pharmacologically induced weight loss via glucagon-like peptide‑1 (GLP-1)-based drugs reduces cardiovascular events to a degree not achieved by lifestyle programs, shifting clinical nutrition toward preservation of lean mass and micronutrient adequacy. By contrast, isolated nutrients and supplements, a specific geroprotective effect of intermittent fasting, and the clinical utility of epigenetic aging clocks remain unproven. Randomized caloric restriction slows the epigenetic pace of aging only modestly and has so far not demonstrated mortality benefit in humans. CONCLUSION: Nutrition acts on cardiovascular longevity mainly through established risk factors rather than through demonstrated extension of maximum lifespan. Nutritional recommendations should make this distinction explicit, and longevity research requires endpoint-driven trials rather than surrogate markers only.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.